(redirected from Loteprednol Etabonate)
Also found in: Medical.
LELimited Edition
LELower East
LELecce (italy)
LELaw Enforcement
LELink Exchange
LELow Energy
LELake Erie (Great Lakes)
LELimit(s) of Error
LELess than or Equal to (computer math)
LELife Expectancy
LELeading Edge
LELeicester (postcode, United Kingdom)
LELegal Entity
LEEgyptian Pound
LELab Equipment
LELife Extension
LELeft End
LELine Equipment
LELast Exile (anime)
LELight Equipment
LELead Engineer
LELicensed Esthetician
LELess or Equal
LELupus Erythematosus
LELarge Enterprise
LELiving Education
LELower Extremity
LELocal Exchange
LELife Estate (inheritance)
LELean Enterprise (management model)
LELubrication Engineers (Fort Worth, TX)
LELight Entertainment
LELearning Express (toy store)
LELater Edit
LELate Entry
LESierra Leone Leone (national currency)
LELanguage Environment
LELine Engraved (philately; Victorian-era style stamps)
LELeucine-Enkephalin (opioid peptide neurotransmitter)
LELateral Epicondylitis
LELicensed Embalmer
LELeft Engine
LELatest Estimate
LELeukocyte Esterase
LELarge Exposure (banking)
LELadder Edition (gaming)
LELow Efficiency
LELuxury Edition
LELAN Emulation
LELegendary Event ((Fallensword gaming)
LELead Equivalent
LELaplacian Eigenmap (algorithm)
LELactation Educator
LELaser Engineer
LELiquid-Expanded (physics)
LELanguage Extender (Microsoft Windows CE)
LELaunch Escape
LELyapunov Exponent
LELinear Error
LELawful Evil (gaming)
LELogic Element
LELaptop Environment
LELow Explosive
LELink Enable(d)
LELoteprednol Etabonate
LELouisiana Eastern (railroad)
LELink Encapsulation (ATM)
LELocus Equations
LELong Eireannach (Gaelic: Ship of Ireland)
LELil’ Ethan (character in NBC's Passions)
LELudus Equinus (gaming website)
LELimited Egress
LEListener Echo-Loss
References in periodicals archive ?
Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs.
Bausch + Lomb said on Friday that it has achieved the primary endpoints in the first Phase 3, multi-centre, double-masked, vehicle-controlled, parallel-group study of its next generation sub-micron gel formulation of loteprednol etabonate.
US-based Kala Pharmaceuticals has commenced Phase II clinical trial (KPI-121-C-004) of its loteprednol etabonate MPP (LE-MPP) drug product, KP-121, in patients with intraretinal or subretinal fluid secondary to retinal vein occlusion (RVO) or diabetic macular oedema (DME), it was reported on Friday.
M2 PHARMA-August 4, 2014-Kala Pharmaceuticals starts Phase II clinical trial of loteprednol etabonate MPP
6) Indeed, the steroid loteprednol etabonate has been shown to be significantly more effective in treating the signs and symptoms of CLGPC compared to a placebo in several randomised controlled trials.
United States-based Kala Pharmaceuticals has started two clinical trials with its nanotechnology-based loteprednol etabonate MPP (LE-MPP) programme, KPI-121, it was reported on Friday.
05% (Durezol) every hour and loteprednol etabonate 0.
The steroid loteprednol etabonate has also demonstrated efficacy in treating the signs and symptoms of CLGPC in several randomised controlled trials.